Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Soluble beta-1,3/1,6-glucan

Drug Profile

Soluble beta-1,3/1,6-glucan

Alternative Names: SBG; Soluble beta-glucan; Woulgan

Latest Information Update: 15 Sep 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biotec Pharmacon
  • Class Antineoplastics; Beta Glucans
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Stomatitis
  • New Molecular Entity No
  • Available For Licensing Yes - Cancer; Stomatitis

Highest Development Phases

  • No development reported Breast cancer; Inflammatory bowel diseases; Influenza virus infections; Neuroblastoma; Non-Hodgkin's lymphoma; Stomatitis
  • Discontinued Diabetic foot ulcer

Most Recent Events

  • 15 Sep 2015 No recent reports on development identified - Phase-I for Non-Hodgkin's lymphoma (Combination therapy) in Norway (PO)
  • 15 Sep 2015 No recent reports on development identified - Phase-I/II for Neuroblastoma (Combination therapy, In children) in USA (PO)
  • 15 Sep 2015 No recent reports on development identified - Preclinical for Inflammatory bowel disease in Norway (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top